Testimonials
If you're looking for thoughtful insights on how AI is influencing managed care pharmacy, AMCP’s Unscripted podcast is a great place to start. It covers how AI is being used to support decision-making, improve patient engagement, and streamline the way we work.
AMCP 2025 AAO Report
AMCP's feature annual report explores how professionals in managed care pharmacy work diligently to facilitate appropriate access to prescription treatments while remaining mindful of rising costs. It discusses key areas of focus such as pharmacy benefit design, formulary management, clinical programs, quality, safety and promoting affordability of medicines.
AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about the new ePoster offering through this tech partnership and platform to support the exchange of clinical and economic information between pharmaceutical companies and payers.
The IPD Analytics platform enables proactive formulary and pharmacy cost management for managed care professionals, with access to clinical pharmacy experts, a wide range of actionable content, and proprietary data and analytics. Gain comprehensive payer and formulary insights, specialty drug access intelligence, pipeline tracking, biosimilar and generic surveillance, medical benefit pricing and coding support, budget impact analysis, and regulatory updates so you can stay ahead of market changes.
AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
AMCP partners with The PVI Company to support a more transparent and efficient approach to evaluating drug value—and give AMCP members opportunities to help shape its evolution. The Payer Value Initiative (PVI) organizes clinical, economic and patient-centered evidence into a structured starting point for review. Through the AMCP–PVI Payer Council and other opportunities to engage with the platform, managed care leaders can contribute their expertise and perspectives as the approach evolves.
-
AI in Managed Care Resources
-
Precision Medicine and Biomarker Testing
-
Health Disparities Resources
-
Real-World Evidence Standards & Resources
-
Patient Voice in Decision-Making
Meetings Proceedings & Findings
View More
Latest News & Resources
In this episode of Unscripted, Steve Kheloussi, Principal Consultant with Kheloussi Consulting, speaks with Rachel Ungar, Director of Research and Data Analytics at the Economic Alliance for Michigan, about bringing employers, health plans, providers, and patient advocates together to improve access to evidence-based precision oncology care. They discuss biomarker testing, payer coverage policies, the importance of aligning testing and treatment decisions, and practical steps health plans can take to reduce barriers while supporting high-quality, cost-effective cancer care.
As psychedelic-assisted therapies move closer to potential use in treating treatment-resistant depression (TRD), health plans, pharmacy benefit managers, and other managed care stakeholders are beginning to evaluate how these therapies could fit within existing coverage, reimbursement, and care delivery models. A new Journal of Managed Care + Specialty Pharmacy (JMCP) supplement from AMCP Market Insights provides a roadmap for many of the questions payers may face as innovative therapies enter the depression treatment landscape.
This article provides key insights and suggested best practices for managed care to improve patient care in MPS disorders, which may also be relevant to other rare and ultra-rare conditions.
What’s driving vaccine hesitancy—and what’s actually true? In this episode of Unscripted, the AMCP Podcast, guest host Steve Kheloussi, PharmD, MBA, FAMCP speaks with Ria Westergaard, Head of Commercial Strategy Intelligence Solutions at Evernorth Health Services, and Rekha Lakshmanan, Executive Director of The Immunization Partnership, about the growing tension between science, policy, and public perception. From misinformation and social media to access gaps and real-world data, they unpack what’s really shaping vaccination decisions today—and where managed care can help rebuild trust and improve outcomes.
Findings from Ryan Haumschild et al Update Understanding of Mucopolysaccharidoses (AMCP Market Insights: The role of managed care in improving patient care in mucopolysaccharidoses): Nutritional and Metabolic Diseases and Conditions – Mucopolysaccharidoses
Reports Outline Follicular Lymphoma Study Results from Denise Wolff et al (AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma): Oncology – Follicular Lymphoma
Researchers from University of Utah Report Findings in Managed Care and Specialty Pharmacy (Optimization of Oncology Biomarker Testing In Managed Care: Best Practices and Consensus Recommendations From an Amcp Market Insights Program): Drugs and Therapies – Managed Care and Specialty Pharmacy
When a 34-year-old patient being treated for stage IV colorectal cancer at Vanderbilt University Medical Center, in Nashville, Tennessee, was notified that his medication was no longer covered by his insurer, he contacted Vanderbilt Specialty Pharmacy. Pharmacists there immediately submitted a prior authorization that was denied, and they were told there was no appeal option.
The role of the pharmacist, managed care pharmacist job satisfaction and artificial intelligence were among the topics that Susan A. Cantrell, CEO of the Academy of Managed Care Pharmacy, discussed with Perry Cohen, Pharm.D., in this episode of "Conversations with Perry and Friends."
This infographic roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
This infographic on Bispecific antibodies describes important things about bsAbs for health care organizations to consider, like choosing the right medication for the right patient and making sure they are available to all patients who might need them.
